Conditions: Type 2 Diabetes
Keywords: diabetes exenatide LY2148568 Byetta Lilly Amylin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 181
Healthy volunteers: no

Brief summary:
This long term, placebo-controlled trial is intended to assess the efficacy and safety of exenatide, dosed twice a day, in Japanese patients with Type 2 Diabetes who are treated with oral antidiabetic(s) but not well controlled.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: exenatide intervention 2: exenatide intervention 3: placebo
Intervention descriptions: intervention 1: subcutaneous injection, 5mcg, twice a day intervention 2: subcutaneous injection, 10mcg, twice a day intervention 3: subcutaneous injection, volume equivalent to 5mcg or 10mcg exenatide, twice a day

Protocol document: